Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...

These popular weight loss medications can come with unwanted side effects—especially if you continue to eat a high-fat diet. Here's what to know and how to avoid it.

MedPage Today brought together three hepatology experts for a virtual roundtable discussion on metabolic ...

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...

Altimmune, Inc. nears key MASH data for pemvidutide—learn investor risks, potential rewards, and what the upcoming results ...

Novo Nordisk’s Wegovy® (semaglutide 2.4 mg) was associated with liver health–related benefits not solely driven by weight ...

This follows recent successful efforts by the Trump administration to cut the price of this compound for certain patients.

Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong leadership positions in distinct therapeutic areas. NVO is widely recognized ...

The U.S. has revealed price reductions for the second round of prescription drugs negotiated by the Centers for Medicare & Medicaid Services (CMS) through the Inflation Reduction Act (IRA). Headlining ...

Marianne Williams is a recipe tester and developer who has been working in the People Inc. test kitchens since 2016. Her recipes are featured in Food & Wine, Southern Living, Real Simple, Rachael Ray, ...

Novo Nordisk A/S shares fell after phase 3 trials showed semaglutide did not slow Alzheimer's progression, though the trials were a longshot due to low optimism. NVO remains fundamentally strong, with ...